CBC Group’s unique and sector-dedicated investment
strategy targets lower risk platform companies with
clear ability to expand business lines

CBC Group’s flagship private equity funds focus on control-oriented platform investments in leading businesses across Asia’s major healthcare sub-sectors including pharmaceutical/ biotech, medical technology and healthcare services

As entrepreneurs who empower other entrepreneurs, we aim to achieve shared long-term growth and alignment with our portfolio partners

CBC Value Creation (CVC)

We actively guide the transformation journeys of our portfolio companies. We utilize our technical expertise, capital resources, government relations, and market channels to recruit best-in-class teams, develop strategic plans and revamp financial risk control systems

Operating Partners

Our operating partners leverage extensive scientific and clinical expertise gleaned from their experience at preeminent multi-national corporations (MNCs), research institutes and financial firms to accelerate growth and enhance value of CBC portfolio companies

Our Portfolio Companies

AffaMed
Anrei
Ascletis
Berry Genomics
CQP
Clarus
CMAB
RDH
Everest Medicines
Fit Samo
JumpCan
Innovent
I-MAB
Lu Daopei Medical
Health 100
NKT
Nuance
info@cbridgecap.com
www.cbridgecap.com
© 2020 CBC Group. All Rights Reserved.